long-term safety and efficacy of ecp in second-line in patients with acute gvhd
Published 1 year ago • 192 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
1:24
the long-term safety and efficacy of ibrutinib monotherapy in patients with previously-treated wm
-
2:15
safety and efficacy of astx727 in patients with cmml from phase ii and phase iii ascertain studies
-
4:14
long-term safety and efficacy of sutimlimab for chronic itp
-
6:38
real-world efficacy & safety of teclistamab in patients with heavily pretreated r/r multiple myeloma
-
1:15
the safety and efficacy of peritransplantation ruxolitinib in patients with mf
-
22:52
haematological emergencies
-
1:01:53
how to use invasive coronary physiology to assess lm disease, pre-tavi and pre-cabg interventions?
-
3:51
sickle cell disease | moa animation
-
3:03
efficacy and safety of vodobatinib by lines of tki therapy in ph cml: a subgroup analysis
-
4:26
phase ib study of orca-t in patients with advanced hematologic malignancies
-
3:52
a phase ii study evaluating the safety and efficacy of olutasidenib in patients with r/r midh1 aml
-
3:50
advances in the prevention and treatment of gvhd
-
2:57
linker-mm1: promising safety and efficacy of linvoseltamab in r/r multiple myeloma
-
0:59
the safety and efficacy of etavopivat in scd
-
1:22
safety and efficacy of cesnicabtagene autoleucel (ari0002h) for r/r mm
-
4:02
elm-2: promising safety and efficacy of odronextamab in r/r dlbcl
-
1:11
long-term safety analysis of pirtobrutinib in r/r b-cell malignancies
-
8:57
outcomes of sct in t-all and t-lbl
-
3:17
estimating transfusion-related medical costs & time burden in patients with mf in simplify-1
-
4:21
recent advances in the management of acute gvhd
-
1:33
outcomes of reduced intensity allosct in patients with accelerated-phase myelofibrosis
-
0:58
management strategies for acute and chronic gvhd following allosct